Patents by Inventor Tomomi Yoshitomi

Tomomi Yoshitomi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL PREPARATION FOR DELIVERY OF POROUS MATERIAL TO LARGE INTESTINE OR LOWER PART OF SMALL INTESTINE
    Publication number: 20180311278
    Abstract: The problem with which the present invention is concerned is providing a novel pharmaceutical preparation, the restrictions on the administration of which to a patient are more relaxed than those of a conventional spherical carbon adsorbent, which can be simultaneously taken with other drugs and, moreover, which is reduced in dosage. The problem can be solved by a pharmaceutical preparation for oral administration comprising a porous material, wherein a means for exposing a surface of the porous material for the first time in the large intestine or a lower part of the small intestine is provided on the porous material.
    Type: Application
    Filed: October 25, 2016
    Publication date: November 1, 2018
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Koji Matsumoto, Tomomi Yoshitomi, Naomi Tanaka, Kazuhiro Yoshida, Yuji Kasuya, Masaoki Ohya
  • N-hetero-ring-substituted amide derivative
    Patent number: 9006273
    Abstract: Compounds having an excellent hypoglycemic effect and ? cell- or pancreas-preserving effects or pharmaceutically acceptable salts thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause hyperglycemia due to abnormal glucose metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: April 14, 2015
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Shigeo Yamanoi, Madoka Hatta, Hidenori Namiki, Koji Matsumoto, Tomomi Yoshitomi
  • N-HETERO-RING-SUBSTITUTED AMIDE DERIVATIVE
    Publication number: 20140221437
    Abstract: Compounds having an excellent hypoglycemic effect and ? cell- or pancreas-preserving effects or pharmaceutically acceptable salts thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause hyperglycemia due to abnormal glucose metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.
    Type: Application
    Filed: July 27, 2012
    Publication date: August 7, 2014
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Shigeo Yamanoi, Madoka Hatta, Hidenori Namiki, Koji Matsumoto, Tomomi Yoshitomi
  • Acylbenzene derivative
    Patent number: 8722711
    Abstract: Provided are compounds having an excellent hypoglycemic action and a ? cell- or pancreas-protecting action or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: May 13, 2014
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Shigeo Yamanoi, Takahiro Katagiri, Hidenori Namiki, Madoka Hatta, Koji Matsumoto, Kanako Takahashi, Tomomi Yoshitomi, Yuichi Ochiai
  • ACYLBENZENE DERIVATIVE
    Publication number: 20130217733
    Abstract: Provided are compounds having an excellent hypoglycemic action and a ? cell- or pancreas-protecting action or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition having an excellent therapeutic effect and/or prophylactic effect on type 1 diabetes, type 2 diabetes, and the like, which cause an increase in the blood sugar level due to abnormal sugar metabolism. A compound represented by general formula (I), or a pharmaceutically acceptable salt thereof, is disclosed.
    Type: Application
    Filed: October 13, 2011
    Publication date: August 22, 2013
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Shigeo Yamanoi, Takahiro Katagiri, Hidenori Namiki, Madoka Hatta, Koji Matsumoto, Kanako Takahashi, Tomomi Yoshitomi, Yuichi Ochiai